{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:32:13Z","timestamp":1783542733115,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03149-7","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:00:47Z","timestamp":1756224047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum metabolic profiling in rheumatic heart disease and degenerative aortic stenosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Daniel W.","family":"Mutithu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry A.","family":"Adeola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olukayode O.","family":"Aremu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn N.","family":"Lumngwena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Familusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Skatulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntobeko A. B.","family":"Ntusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"2","key":"3149_CR1","doi-asserted-by":"publisher","first-page":"020404","DOI":"10.7189\/jogh.10.020404","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen, J., Li, W. & Xiang, M. Burden of valvular heart disease, 1990\u20132017: results from the global burden of disease study 2017. J. Glob Health. 10 (2), 020404 (2020).","journal-title":"J. Glob Health"},{"issue":"23","key":"3149_CR2","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1161\/CIRCULATIONAHA.105.539775","volume":"112","author":"MR Essop","year":"2005","unstructured":"Essop, M. R. & Nkomo, V. T. Rheumatic and nonrheumatic valvular heart disease. Circulation 112 (23), 3584\u20133591 (2005).","journal-title":"Circulation"},{"issue":"3","key":"3149_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41569-019-0258-2","volume":"17","author":"B Muhamed","year":"2020","unstructured":"Muhamed, B., Parks, T. & Sliwa, K. Genetics of rheumatic fever and rheumatic heart disease. Nat. Rev. Cardiol. 17 (3), 145\u2013154 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"3149_CR4","doi-asserted-by":"publisher","first-page":"612716","DOI":"10.3389\/fcvm.2020.612716","volume":"7","author":"LSA Passos","year":"2021","unstructured":"Passos, L. S. A., Nunes, M. C. P. & Aikawa, E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front. Cardiovasc. Med. 7, 612716 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"3149_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MED.0000000000000471","volume":"26","author":"HY Chen","year":"2019","unstructured":"Chen, H. Y., Engert, J. C. & Thanassoulis, G. Risk factors for valvular calcification. Curr. Opin. Endocrinol. Diabetes Obes. 26 (2), 96\u2013102 (2019).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"9","key":"3149_CR6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/CIRCRESAHA.120.317979","volume":"128","author":"MC Blaser","year":"2021","unstructured":"Blaser, M. C., Kraler, S., Luscher, T. F. & Aikawa, E. Multi-omics approaches to define calcific aortic valve disease pathogenesis. Circ. Res. 128 (9), 1371\u20131397 (2021).","journal-title":"Circ. Res."},{"issue":"11","key":"3149_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","volume":"66","author":"R Capoulade","year":"2015","unstructured":"Capoulade, R. et al. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J. Am. Coll. Cardiol. 66 (11), 1236\u20131246 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"3149_CR8","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 143 (5), e72\u2013e227 (2021).","journal-title":"Circulation"},{"key":"3149_CR9","doi-asserted-by":"crossref","unstructured":"Everett, R. J., Clavel, M-A., Pibarot, P. & Dweck, M. R. Timing of intervention in aortic stenosis: a review of current and future strategies. Heart 104 (24), 2067 LP \u2013 2076. (2018).","DOI":"10.1136\/heartjnl-2017-312304"},{"issue":"10","key":"3149_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger, R. D. et al. Metabolomics enables precision medicine: A white paper, community perspective. Metabolomics 12 (10), 149 (2016).","journal-title":"Metabolomics"},{"issue":"3","key":"3149_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mas.21548","volume":"38","author":"M Jacob","year":"2019","unstructured":"Jacob, M., Lopata, A. L. & Dasouki, M. Abdel Rahman A.M. Metabolomics toward personalized medicine. Mass Spectrom. Rev. 38 (3), 221\u2013238 (2019).","journal-title":"Mass Spectrom. Rev."},{"issue":"1","key":"3149_CR12","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1038\/s41598-022-09191-z","volume":"12","author":"S Das","year":"2022","unstructured":"Das, S. et al. An untargeted LC\u2013MS based approach for identification of altered metabolites in blood plasma of rheumatic heart disease patients. Sci. Rep. 12 (1), 5238 (2022).","journal-title":"Sci. Rep."},{"issue":"3","key":"3149_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00392-022-01992-6","volume":"111","author":"M Amrein","year":"2022","unstructured":"Amrein, M. et al. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Clin. Res. Cardiol. 111 (3), 692\u2013704 (2022).","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"3149_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/life13010182","volume":"13","author":"E Neculae","year":"2023","unstructured":"Neculae, E. et al. The oral microbiota in valvular heart disease: current knowledge and future directions. Life 13 (1), 182 (2023).","journal-title":"Life"},{"issue":"7","key":"3149_CR15","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.3390\/ijms22073569","volume":"22","author":"BO van Driel","year":"2021","unstructured":"van Driel, B. O. et al. Metabolomics in severe aortic stenosis reveals intermediates of nitric oxide synthesis as most distinctive markers. Int. J. Mol. Sci. 22 (7), 3569 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"3149_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12872-020-01491-4","volume":"20","author":"T-Y Xiong","year":"2020","unstructured":"Xiong, T-Y. et al. Differences in metabolic profiles between bicuspid and tricuspid aortic stenosis in the setting of transcatheter aortic valve replacement. BMC Cardiovasc. Disord. 20, 229 (2020).","journal-title":"BMC Cardiovasc. Disord"},{"issue":"7","key":"3149_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","volume":"2","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat. Metab. 2 (7), 635\u2013647 (2020).","journal-title":"Nat. Metab."},{"issue":"5","key":"3149_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","volume":"9","author":"B Rem\u00e9nyi","year":"2012","unstructured":"Rem\u00e9nyi, B. et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat. Rev. Cardiol. 9 (5), 297\u2013309 (2012).","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"3149_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for Cardio-Thoracic surgery (EACTS). Eur. Heart J. 43 (7), 561\u2013632 (2022).","journal-title":"Eur. Heart J."},{"issue":"18","key":"3149_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.114.010236","volume":"130","author":"MS Farvid","year":"2014","unstructured":"Farvid, M. S. et al. Dietary Linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 130 (18), 1568\u20131578 (2014).","journal-title":"Circulation"},{"issue":"8","key":"3149_CR21","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3390\/nu12082329","volume":"12","author":"E Froyen","year":"2020","unstructured":"Froyen, E. & Burns-Whitmore, B. The effects of Linoleic acid consumption on lipid risk markers for cardiovascular disease in healthy individuals: a review of human intervention trials. Nutrients 12 (8), 2329 (2020).","journal-title":"Nutrients"},{"issue":"10","key":"3149_CR22","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/ATVBAHA.122.318048","volume":"42","author":"A Zietzer","year":"2022","unstructured":"Zietzer, A., D\u00fcsing, P., Reese, L., Nickenig, G. & Jansen, F. Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential. Arterioscler. Thromb. Vasc Biol. 42 (10), 1220\u20131228 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"3","key":"3149_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1017\/S1047951111000047","volume":"21","author":"NM Habeeb","year":"2011","unstructured":"Habeeb, N. M. & Al Hadidi, I. S. Ongoing inflammation in children with rheumatic heart disease. Cardiol. Young. 21 (3), 334\u2013339 (2011).","journal-title":"Cardiol. Young"},{"issue":"7","key":"3149_CR24","doi-asserted-by":"publisher","first-page":"ytac278","DOI":"10.1093\/ehjcr\/ytac278","volume":"6","author":"DW Mutithu","year":"2022","unstructured":"Mutithu, D. W., Roberts, R. & Manganyi, R. Ntusi N.A.B. Chronic rheumatic heart disease with recrudescence of acute rheumatic fever on histology: a case report. Eur. Hear. J. - Case Rep. 6 (7), ytac278 (2022).","journal-title":"Eur. Hear. J. - Case Rep."},{"issue":"2","key":"3149_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.phanu.2016.02.001","volume":"4","author":"LB Richards","year":"2016","unstructured":"Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J. & Folkerts, G. The effects of short-chain fatty acids on the cardiovascular system. PharmaNutrition 4 (2), 68\u2013111 (2016).","journal-title":"PharmaNutrition"},{"issue":"18","key":"3149_CR26","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/nu14183758","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao, P., Zhao, S., Tian, J. & Liu, X. Significance of gut microbiota and short-chain fatty acids in heart failure. Nutrients 14 (18), 3758 (2022).","journal-title":"Nutrients"},{"issue":"1","key":"3149_CR27","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager, H. M. & Licht, T. R. Microbial Tryptophan catabolites in health and disease. Nat. Commun. 9 (1), 3294 (2018).","journal-title":"Nat. Commun."},{"key":"3149_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","volume":"8","author":"LS Zhang","year":"2016","unstructured":"Zhang, L. S. & Davies, S. S. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 8, 46 (2016).","journal-title":"Genome Med."},{"key":"3149_CR29","doi-asserted-by":"publisher","first-page":"643092","DOI":"10.3389\/fcimb.2021.643092","volume":"11","author":"X-R Shi","year":"2021","unstructured":"Shi, X-R. et al. Microbiota in gut, oral cavity, and mitral valves are associated with rheumatic heart disease. Front. Cell. Infect. Microbiol. 11, 643092 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"3149_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijcard.2015.06.048","volume":"197","author":"PA Vorkas","year":"2015","unstructured":"Vorkas, P. A. et al. Perturbations in fatty acid metabolism and apoptosis are manifested in calcific coronary artery disease: an exploratory lipidomic study. Int. J. Cardiol. 197, 192\u2013199 (2015).","journal-title":"Int. J. Cardiol."},{"key":"3149_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fcvm.2018.00172","volume":"5","author":"Y Tintut","year":"2018","unstructured":"Tintut, Y., Hsu, J. J. & Demer, L. L. Lipoproteins in cardiovascular calcification: potential targets and challenges. Front. Cardiovasc. Med. 5, 172 (2018).","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"3149_CR32","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen, J. N. et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta - Biomembr. 1859 (9), 1558\u20131572 (2017).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"issue":"3","key":"3149_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/157340309788970379","volume":"5","author":"MN Jameel","year":"2009","unstructured":"Jameel, M. N. & Zhang, J. Myocardial energetics in left ventricular hypertrophy. Curr. Cardiol. Rev. 5 (3), 243\u2013250 (2009).","journal-title":"Curr. Cardiol. Rev."},{"key":"3149_CR34","doi-asserted-by":"publisher","first-page":"602100","DOI":"10.3389\/fcvm.2020.602100","volume":"7","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Variations in energy metabolism precede alterations in cardiac structure and function in hypertrophic preconditioning. Front. Cardiovasc. Med. 7, 602100 (2020).","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"3149_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12013-013-9750-1","volume":"68","author":"M Akram","year":"2014","unstructured":"Akram, M. Citric acid cycle and role of its intermediates in metabolism. Cell. Biochem. Biophys. 68 (3), 475\u2013478 (2014).","journal-title":"Cell. Biochem. Biophys."},{"issue":"1","key":"3149_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/157340308783565429","volume":"4","author":"A Chabowski","year":"2008","unstructured":"Chabowski, A. et al. Protein-mediated fatty acid uptake in the heart. Curr. Cardiol. Rev. 4 (1), 12\u201321 (2008).","journal-title":"Curr. Cardiol. Rev."},{"issue":"4","key":"3149_CR37","doi-asserted-by":"publisher","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","volume":"291","author":"D An","year":"2006","unstructured":"An, D. & Rodrigues, B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am. J. Physiol. Circ. Physiol. 291 (4), H1489\u2013H1506 (2006).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"issue":"8","key":"3149_CR38","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/ATVBAHA.116.308761","volume":"37","author":"PR Kamstrup","year":"2017","unstructured":"Kamstrup, P. R., Hung, M-Y., Witztum, J. L., Tsimikas, S. & Nordestgaard, B. G. Oxidized phospholipids and risk of calcific aortic valve disease: the Copenhagen general population study. Arterioscler. Thromb. Vasc Biol. 37 (8), 1570\u20131578 (2017).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"1","key":"3149_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal. Transduct. Target. Ther. 7 (1), 265 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"3149_CR40","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms24043534","volume":"24","author":"AS Manolis","year":"2023","unstructured":"Manolis, A. S., Manolis, T. A. & Manolis, A. A. Ketone bodies and cardiovascular disease: an alternate fuel source to the rescue. Int. J. Mol. Sci. 24 (4), 3534 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"68","key":"3149_CR41","first-page":"1","volume":"15","author":"HA Haijes","year":"2020","unstructured":"Haijes, H. A., Jans, J. J. M., van der Ham, M., van Hasselt, P. M. & Verhoeven-Duif, N. M. Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach. Orphanet J. Rare Dis. 15 (68), 1\u201313 (2020).","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"3149_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rehab.2016.09.002","volume":"60","author":"J-C Chauvet-Gelinier","year":"2017","unstructured":"Chauvet-Gelinier, J-C. & Bonin, B. Stress, anxiety and depression in heart disease patients: A major challenge for cardiac rehabilitation. Ann. Phys. Rehabil Med. 60 (1), 6\u201312 (2017).","journal-title":"Ann. Phys. Rehabil Med."},{"issue":"16","key":"3149_CR43","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.3390\/molecules26164913","volume":"26","author":"CJ Jong","year":"2021","unstructured":"Jong, C. J., Sandal, P. & Schaffer, S. W. The role of taurine in mitochondria health: more than just an antioxidant. Molecules 26 (16), 4913 (2021).","journal-title":"Molecules"},{"issue":"Suppl 1","key":"3149_CR44","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1423-0127-17-S1-S2","volume":"17","author":"SW Schaffer","year":"2010","unstructured":"Schaffer, S. W., Ju Jong, C., Azuma, J. & KC R. & Physiological roles of taurine in heart and muscle. J. Biomed. Sci. 17 (Suppl 1), S2 (2010).","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"3149_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1139\/cjpp-2019-0313","volume":"98","author":"G Bkaily","year":"2019","unstructured":"Bkaily, G. et al. Taurine and cardiac disease: state of the Art and perspectives. Can. J. Physiol. Pharmacol. 98 (2), 67\u201373 (2019).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"3149_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41420-022-01200-4","volume":"8","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases. Cell. Death Discov. 8 (1), 413 (2022).","journal-title":"Cell. Death Discov"},{"issue":"8","key":"3149_CR47","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.107.169573","volume":"102","author":"S Ryoo","year":"2008","unstructured":"Ryoo, S. et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ. Res. 102 (8), 923\u2013932 (2008).","journal-title":"Circ. Res."},{"issue":"4","key":"3149_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/nu13041215","volume":"13","author":"M Balestrino","year":"2021","unstructured":"Balestrino, M. Role of creatine in the heart: health and disease. Nutrients 13 (4), 1215 (2021).","journal-title":"Nutrients"},{"issue":"6","key":"3149_CR49","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/1535370215584931","volume":"240","author":"DE Farthing","year":"2015","unstructured":"Farthing, D. E., Farthing, C. A. & Xi, L. Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care. Exp. Biol. Med. 240 (6), 821\u2013831 (2015).","journal-title":"Exp. Biol. Med."},{"issue":"7","key":"3149_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6 (7), 1060\u20131083 (2011).","journal-title":"Nat. Protoc."},{"issue":"10","key":"3149_CR51","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30 (10), 918\u2013920 (2012).","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"3149_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS Deconvolution for comprehensive metabolome analysis. Nat. Methods. 12 (6), 523\u2013526 (2015).","journal-title":"Nat. Methods"},{"issue":"W1","key":"3149_CR53","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between Raw spectra and functional insights. Nucleic Acids Res. 49 (W1), W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"3149_CR54","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nbt.3597","volume":"34","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat. Biotechnol. 34 (8), 828\u2013837 (2016).","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"3149_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41592-019-0344-8","volume":"16","author":"K D\u00fchrkop","year":"2019","unstructured":"D\u00fchrkop, K. et al. SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information. Nat. Methods. 16 (4), 299\u2013302 (2019).","journal-title":"Nat. Methods"},{"key":"3149_CR56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2018.02.046","volume":"54","author":"A de la Gil","year":"2018","unstructured":"de la Gil, A. et al. Knowledge-based metabolite annotation tool: CEU mass mediator. J. Pharm. Biomed. Anal. 54, 138\u2013149 (2018).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"3149_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"3149_CR58","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03149-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:32:40Z","timestamp":1757442760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03149-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03149-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Faculty of Health Science, Human Research Ethics Committee, University of Cape Town (HREC REF: 574\/2018 & HREC REF: 061\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"31470"}}